mitomycin has been researched along with Behcet Syndrome in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
Excerpt | Relevance | Reference |
---|---|---|
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 7.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 7.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 7.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 3.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 3.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 3.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komae, K | 1 |
Takamoto, M | 1 |
Tanaka, R | 1 |
Aihara, M | 1 |
Ohtomo, K | 1 |
Okinaga, K | 1 |
Matsuda, J | 1 |
Nakahara, H | 1 |
Fujino, Y | 1 |
Kaburaki, T | 1 |
Yalvac, IS | 1 |
Sungur, G | 1 |
Turhan, E | 1 |
Eksioglu, U | 1 |
Duman, S | 1 |
Elgin, U | 1 |
Berker, N | 1 |
Batman, A | 1 |
Soykan, E | 1 |
Peavy, DL | 1 |
Nelms, DC | 1 |
Mackler, BF | 1 |
4 other studies available for mitomycin and Behcet Syndrome
Article | Year |
---|---|
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2017 |
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu | 2004 |
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M | 2007 |
Failure of autologous oral epithelia to activate RAS lymphocytes.
Topics: Behcet Syndrome; Epithelial Cells; Epithelium; Humans; Lymphocyte Activation; Mitomycin; Mitomycins; | 1982 |